ZACCARDELLI DAVID — SEC Form 4 filings
SEC reporting owner CIK 1627642. 25 Form 4 filings on record with FilingPulse; latest filed 2026-07-09.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-02-05 to 2026-07-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 14 filings — 4,486,280 shares, $29,210,507 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 400,000 shares @ $11.40 ($4,560,520) in Verona Pharma plc, filed 2025-06-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) | President and CEO, Director | 23 | — | 29 legs · 4,486,280 sh · $29,210,507 | 32 |
| SAB Biotherapeutics, Inc. (SABS) | Director | 1 | — | — | 1 |
| Vor Biopharma Inc. (VOR) | Director | 1 | — | — | 1 |
Form 4 filings — ZACCARDELLI DAVID
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-09 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 42,658 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Verona Pharma plc (VRNA) | Disposition to issuer (D): 12,176,144 · Option exercise (M): 3,285,280 · Disposition to issuer (D): 3,285,280 · Option exercise (M): 800,000 (derivative) · Option exercise (M): 389,792 (derivative) · Option exercise (M): 445,536 (derivative) · +2 more | EDGAR |
| 2025-09-03 | 4 | Verona Pharma plc (VRNA) | Gift (G): 1,200,000 @ $0 | EDGAR |
| 2025-08-05 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 255,696 @ $0 · Sale (S): 208,912 @ $13.14 · Option exercise (M): 200,000 (derivative) @ $0 · Option exercise (M): 55,696 (derivative) @ $0 | EDGAR |
| 2025-07-09 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 229,512 @ $0 · Tax withholding (F): 90,320 @ $11.44 · Grant/award (A): 675,048 (derivative) @ $0 · Option exercise (M): 229,512 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Verona Pharma plc (VRNA) | Sale (S): 400,000 @ $11.40 | EDGAR |
| 2025-05-29 | 4 | Verona Pharma plc (VRNA) | Sale (S): 33,600 @ $9.53 · Sale (S): 157,704 @ $9.30 · Sale (S): 208,696 @ $9.33 | EDGAR |
| 2025-05-05 | 4 | Verona Pharma plc (VRNA) | Sale (S): 108,272 @ $8.95 · Option exercise (M): 200,000 · Sale (S): 78,736 @ $8.95 · Sale (S): 400,000 @ $9.09 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 229,512 @ $0 · Sale (S): 90,360 @ $8.98 · Grant/award (A): 1,200,000 (derivative) @ $0 · Grant/award (A): 675,000 (derivative) @ $0 · Option exercise (M): 229,512 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 200,000 @ $0 · Tax withholding (F): 166,728 @ $7.16 | EDGAR |
| 2024-12-06 | 4 | Verona Pharma plc (VRNA) | Sale (S): 67,608 @ $5.00 · Sale (S): 640,264 @ $5.01 · Sale (S): 162,800 @ $5.01 | EDGAR |
| 2024-12-02 | 4 | Verona Pharma plc (VRNA) | Sale (S): 23,240 @ $5 · Sale (S): 98,888 @ $5.01 · Sale (S): 3,200 @ $5 | EDGAR |
| 2024-11-26 | 4 | Verona Pharma plc (VRNA) | Sale (S): 1,600 @ $5 | EDGAR |
| 2024-11-13 | 4 | Verona Pharma plc (VRNA) | Sale (S): 2,400 @ $5 | EDGAR |
| 2024-11-05 | 4 | Verona Pharma plc (VRNA) | Sale (S): 46,888 @ $4.38 · Sale (S): 94,144 @ $4.39 | EDGAR |
| 2024-11-01 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 800,000 @ $0 · Grant/award (A): 200,000 @ $0 · Tax withholding (F): 245,952 @ $4.24 | EDGAR |
| 2024-10-25 | 4 | Verona Pharma plc (VRNA) | Sale (S): 16 @ $4.38 · Sale (S): 140,000 @ $4.38 · Sale (S): 4,800 @ $4.38 | EDGAR |
| 2024-10-22 | 4 | Verona Pharma plc (VRNA) | Sale (S): 245,784 @ $4.38 · Sale (S): 110,456 @ $4.38 · Sale (S): 157,912 @ $4.39 | EDGAR |
| 2024-09-13 | 4 | Verona Pharma plc (VRNA) | Sale (S): 600,000 @ $3.76 | EDGAR |
| 2024-08-14 | 4 | Verona Pharma plc (VRNA) | Sale (S): 1,600 @ $3.13 · Sale (S): 390,184 @ $3.20 · Sale (S): 8,216 @ $3.25 | EDGAR |
| 2024-08-09 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 800,000 @ $0 · Tax withholding (F): 314,800 @ $2.62 | EDGAR |
| 2024-08-05 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 88,544 @ $2.83 | EDGAR |
| 2024-05-03 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 88,544 @ $1.93 | EDGAR |
| 2024-02-05 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 480,200 @ $2.29 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1627642 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →